Clinical Trial Update: Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating safety, immunogenicity, and efficacy of a candidate malaria vaccine (Pf malaria).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria Falciparum

Drugs mentioned

• candidate malaria vaccine

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Malaria, Falciparum | Phase 2 | Status: COMPLETED | Results posted: 2020-05-21